Dassault Systèmes BIOVIA

Through the adoption of a data driven and automated CMC Dossier generation process, pharmaceutical companies can reduce time-to-market while delivering significant cost savings to the organization. Eliminate errors, duplicate data entry and verification, create a digital chain of evidence and significantly reduce time spent on CMC authoring.